These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24576513)

  • 1. The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial.
    Vink EE; de Beus E; de Jager RL; Voskuil M; Spiering W; Vonken EJ; de Wit GA; Roes KC; Bots ML; Blankestijn PJ
    Am Heart J; 2014 Mar; 167(3):308-314.e3. PubMed ID: 24576513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL; de Beus E; Beeftink MM; Sanders MF; Vonken EJ; Voskuil M; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Hypertension; 2017 Apr; 69(4):678-684. PubMed ID: 28264922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
    Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C; Papademetriou V; Tsiachris D; Kasiakogias A; Kordalis A; Thomopoulos C; Dimitriadis K; Tousoulis D; Stefanadis C; Parati G; Worthley S
    Int J Cardiol; 2015 Feb; 180():237-42. PubMed ID: 25463375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation.
    Olsen LK; Kamper AL; Svendsen JH; Feldt-Rasmussen B
    Eur J Intern Med; 2015 Mar; 26(2):95-105. PubMed ID: 25676808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and long-term effects of renal denervation: Rationale and design of the Dutch registry.
    Sanders MF; Blankestijn PJ; Voskuil M; Spiering W; Vonken EJ; Rotmans JI; van der Hoeven BL; Daemen J; van den Meiracker AH; Kroon AA; de Haan MW; Das M; Bax M; van der Meer IM; van Overhagen H; van den Born BJ; van Brussel PM; van der Valk PH; Smak Gregoor PJ; Meuwissen M; Gomes ME; Oude Ophuis T; Troe E; Tonino WA; Konings CJ; de Vries PA; van Balen A; Heeg JE; Smit JJ; Elvan A; Steggerda R; Niamut SM; Peels JO; de Swart JB; Wardeh AJ; Groeneveld JH; van der Linden E; Hemmelder MH; Folkeringa R; Stoel MG; Kant GD; Herrman JP; van Wissen S; Deinum J; Westra SW; Aengevaeren WR; Parlevliet KJ; Schramm A; Jessurun GA; Rensing BJ; Winkens MH; Wierema TK; Santegoets E; Lipsic E; Houwerzijl E; Kater M; Allaart CP; Nap A; Bots ML
    Neth J Med; 2016 Jan; 74(1):5-15. PubMed ID: 26819356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
    Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB
    J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in multiple renal arteries.
    Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M
    Eur J Clin Invest; 2014 Aug; 44(8):728-35. PubMed ID: 24931208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
    Hering D; Lambert EA; Marusic P; Ika-Sari C; Walton AS; Krum H; Sobotka PA; Mahfoud F; Böhm M; Lambert GW; Esler MD; Schlaich MP
    J Hypertens; 2013 Sep; 31(9):1893-900. PubMed ID: 23697964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of hypertension resistant to treatment and indication for renal denervation].
    Rosenbaum D; Villeneuve F; Gury C; Girerd X
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):229-33. PubMed ID: 22677181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J
    Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
    Mahfoud F; Weber M; Schmieder RE; Lobo MD; Blankestijn PJ; Persu A; Fischell TA; Parise H; Pathak A; Kandzari DE
    Am Heart J; 2021 Sep; 239():90-99. PubMed ID: 34052211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.